Burns

Background

The American Burn Association estimates that burn injuries claim the lives of at least 3,000 United States civilians and send another 500,000 to seek medical attention each year, of which 40,000 cases require hospitalization. Annual US expenditure on burn injuries is more than $2B in direct costs, with immeasurable indirect costs.  Of burn patients admitted to hospitals, 10% have burns that exceed 30% of the Total Body Surface Area (TBSA). In addition, burns represent 5 to 20% of all combat related injuries; 20% of which are considered severe or involve more than 20% of TBSA. These burns result in significant morbidity and mortality, as well as long-term complications including functional impairment and aesthetic disfigurement. 

 

Burns are dynamic injuries characterized by progressive extension of the size and severity (depth) of the burn over the course of several days. Burn progression is a well-known, but not completely understood phenomenon, with no FDA-approved preventative treatment.

Healing or Burn Progression

Burn Injury Progression

Leads to increased:

• morbidity

• healing time

• costs

• scarring

Heal

Scar

Contracture

Images from A.D.A.M.
Current Therapies

Current treatments do not limit or prevent burn injury progression, speed healing of burn tissue or mitigate scarring. 

Standard of Care

  • Prevent shock

  • Prevent and/or treat infection

  • Pain relief

  • Nutritional care

  • Dressings and Debridement

  • Skin grafts

  • Surgical scar revision

  • Rehabilitation

NeoMatrix Potential Therapies

 

Our product candidates have the potential to limit burn injury progression to:

  • Speed wound closure

  • Reduce inflammation and scarring

  • Decrease surgery

  • Decrease costs of treatment and  rehabilitation

  • Reduce disfigurement and disability

  • Restore patient to full employment or active duty

NeoMatrix Therapeutics

25 Health Sciences Drive, Suite 124

Stony Brook, NY 11790

© 2020 NeoMatrix Therapeutics, Inc. All rights reserved.